Resumen

CALDERON, Katherine; HERNANDEZ, Adriana; OSORIO, Luis F.  y  LANZA, Stephany. Nonalcoholic fatty liver disease and potential effects of β-glucans in its treatment: A literature review. Rev. chil. nutr. [online]. 2022, vol.49, n.1, pp.100-107. ISSN 0717-7518.  http://dx.doi.org/10.4067/S0717-75182022000100100.

Non-alcoholic fatty liver disease is considered a public health problem, characterized by the accumulation of fatty acids and triglycerides in the cytoplasm of hepatocytes, resulting in an increase in the total weight of the liver, ranging from a non-alcoholic hepatic steatosis (absence of inflammation) to non-alcoholic steatohepatitis (presence of inflammation), fibrosis and even hepatocarcinoma. Currently, there are no treatments approved by regulatory agencies for the disease, which has led to a high prevalence of liver disease worldwide. The β-glucans are homopolysaccharides of glucose to which fat-reducing properties are attributed since they are considered dietary fiber. The importance and effects of β-glucans in the diet for the prevention of nonalcoholic fatty liver disease are highlighted in this literature review.

Palabras clave : Fatty liver; Health; Prevention; Treatment; Triglycerides.

        · resumen en Español     · texto en Español     · Español ( pdf )